These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. N'Kontchou G, Aout M, Laurent A, Nahon P, Ganne-Carrié N, Grando V, Baghad I, Roulot D, Trinchet JC, Sellier N, Cherqui D, Vicaut E, Beaugrand M, Seror O. J Hepatol; 2012 Jan; 56(1):160-6. PubMed ID: 21703186 [Abstract] [Full Text] [Related]
4. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor. Vitale A, Farinati F, Burra P, Trevisani F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Svegliati Baroni G, Virdone R, Chiaramonte M, Spolverato G, Cillo U, Italian Liver Cancer Group. Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802 [Abstract] [Full Text] [Related]
5. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539 [Abstract] [Full Text] [Related]
7. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Sapisochin G, Castells L, Dopazo C, Bilbao I, Minguez B, Lázaro JL, Allende H, Balsells J, Caralt M, Charco R. Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574 [Abstract] [Full Text] [Related]
9. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C. Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927 [Abstract] [Full Text] [Related]
11. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA. Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [Abstract] [Full Text] [Related]
12. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Lim KC, Wang VW, Siddiqui FJ, Shi L, Chan ES, Oh HC, Tan SB, Chow PK. Hepatology; 2015 Jan; 61(1):227-37. PubMed ID: 24638991 [Abstract] [Full Text] [Related]
13. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, Angeli P, Cillo U. Hepatology; 2010 Jan; 51(1):165-73. PubMed ID: 19877181 [Abstract] [Full Text] [Related]
16. Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent. Muaddi H, Al-Adra DP, Beecroft R, Ghanekar A, Moulton CA, Doyle A, Selzner M, Wei A, McGilvray ID, Gallinger S, Grant DR, Cattral MS, Greig PD, Kachura J, Cleary SP, Sapisochin G. Ann Surg Oncol; 2018 Apr; 25(4):991-999. PubMed ID: 29327179 [Abstract] [Full Text] [Related]